<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1646-5830</journal-id>
<journal-title><![CDATA[Acta Obstétrica e Ginecológica Portuguesa]]></journal-title>
<abbrev-journal-title><![CDATA[Acta Obstet Ginecol Port]]></abbrev-journal-title>
<issn>1646-5830</issn>
<publisher>
<publisher-name><![CDATA[Euromédice, Edições Médicas Lda.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1646-58302024000400300</article-id>
<article-id pub-id-type="doi">10.69729/aogp.v18i4a05</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Fatores de risco e prognóstico na Doença Gestacional do Trofoblasto]]></article-title>
<article-title xml:lang="en"><![CDATA[Risk factors and prognosis of Gestational Trophoblastic Disease]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Marques]]></surname>
<given-names><![CDATA[Mariana Lopes]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[Isabel Santos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidade de Coimbra Faculdade de Medicina ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Centro Hospitalar e Universitário de Coimbra  ]]></institution>
<addr-line><![CDATA[Coimbra ]]></addr-line>
<country>Portugal</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2024</year>
</pub-date>
<volume>18</volume>
<numero>4</numero>
<fpage>300</fpage>
<lpage>307</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S1646-58302024000400300&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S1646-58302024000400300&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S1646-58302024000400300&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo A Doença Gestacional do Trofoblasto (DGT) é um conjunto heterogéneo de doenças raras relacionadas com o desenvolvimento anormal do trofoblasto na gravidez. Entre os fatores de risco associados destacam-se a idade materna avançada e antecedente de gestação molar, que variam de acordo com o subtipo de anomalia. A determinação do prognóstico, nas formas benignas, é feita pela monitorização dos valores de gonadotropina coriónica humana sanguínea (&#946;-hCG), após tratamento. Nas formas malignas, é estabelecido pela correlação entre dois sistemas de classificação que permite categorizar os tumores em grupos de risco de resistência ao tratamento.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Gestational trophoblast disease (GTD) is a heterogeneous group of rare diseases related to the abnormal development of the trophoblast during pregnancy. Associated risk factors include advanced maternal age and a history of molar pregnancy, which vary according to the subtype of anomaly. In benign forms, prognosis is determined by monitoring blood human chorionic gonadotropin (&#946;-hCG) values after treatment. In malignant forms, it is established by the correlation between two classification systems that allow tumours to be categorized into risk groups for resistance to treatment.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Doença gestacional do trofoblasto]]></kwd>
<kwd lng="pt"><![CDATA[Mola hidatiforme]]></kwd>
<kwd lng="pt"><![CDATA[Neoplasia gestacional do trofoblasto]]></kwd>
<kwd lng="pt"><![CDATA[Fatores de risco]]></kwd>
<kwd lng="pt"><![CDATA[Prognóstico.]]></kwd>
<kwd lng="en"><![CDATA[Gestational trophoblastic disease]]></kwd>
<kwd lng="en"><![CDATA[Hydatidiform mole]]></kwd>
<kwd lng="en"><![CDATA[Gestational trophoblastic neoplasia]]></kwd>
<kwd lng="en"><![CDATA[Risk factors]]></kwd>
<kwd lng="en"><![CDATA[Prognosis.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nica]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bouchard-Fortier]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Covens]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gestational trophoblastic disease]]></article-title>
<source><![CDATA[Comprehensive Gynecology]]></source>
<year>2022</year>
<edition>8th Edition</edition>
<page-range>754-767e3</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stevens]]></surname>
<given-names><![CDATA[FT]]></given-names>
</name>
<name>
<surname><![CDATA[Katzorke]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Tempfer]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Kreimer]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Bizjak]]></surname>
<given-names><![CDATA[GI]]></given-names>
</name>
<name>
<surname><![CDATA[Fleisch]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gestational Trophoblastic Disorders An Update in 2015. Geburtshilfe Frauenheilkd]]></article-title>
<source><![CDATA[Outubro de]]></source>
<year>2015</year>
<volume>75</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1043-50</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lukinovic]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Malovrh]]></surname>
<given-names><![CDATA[EP]]></given-names>
</name>
<name>
<surname><![CDATA[Takac]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Sobocan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Knez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Advances in diagnostics and management of gestational trophoblastic disease]]></article-title>
<source><![CDATA[Radiol Oncol. 1 de Dezembro de]]></source>
<year>2022</year>
<volume>56</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>430-9</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frijstein]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Lok]]></surname>
<given-names><![CDATA[CAR]]></given-names>
</name>
<name>
<surname><![CDATA[van Trommel]]></surname>
<given-names><![CDATA[NE]]></given-names>
</name>
<name>
<surname><![CDATA[Ten Kate-Booij]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Massuger]]></surname>
<given-names><![CDATA[LFAG]]></given-names>
</name>
<name>
<surname><![CDATA[van Werkhoven]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management and prognostic factors of epithelioid trophoblastic tumors Results from the International Society for the Study of Trophoblastic Diseases database. Gynecol Oncol]]></article-title>
<source><![CDATA[Fevereiro de]]></source>
<year>2019</year>
<volume>152</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>361-7</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tempfer]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Horn]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
<name>
<surname><![CDATA[Ackermann]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Beckmann]]></surname>
<given-names><![CDATA[MW]]></given-names>
</name>
<name>
<surname><![CDATA[Dittrich]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Einenkel]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gestational and Non-gestational Trophoblastic Disease Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 032/049, December 2015). Geburtshilfe Frauenheilkd]]></article-title>
<source><![CDATA[Fevereiro de]]></source>
<year>2016</year>
<volume>76</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>134-44</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Horowitz]]></surname>
<given-names><![CDATA[NS]]></given-names>
</name>
<name>
<surname><![CDATA[Eskander]]></surname>
<given-names><![CDATA[RN]]></given-names>
</name>
<name>
<surname><![CDATA[Adelman]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Burke]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology, diagnosis, and treatment of gestational trophoblastic disease A Society of Gynecologic Oncology evidenced-based review and recommendation. Gynecol Oncol]]></article-title>
<source><![CDATA[Dezembro de]]></source>
<year>2021</year>
<volume>163</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>605-13</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tidy]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Seckl]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hancok]]></surname>
<given-names><![CDATA[BW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of Gestational Trophoblastic Disease Green-top Guideline No. 38 - June 2020]]></article-title>
<source><![CDATA[BJOG. 1 de Fevereiro de]]></source>
<year>2021</year>
<volume>128</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>e1-27</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lok]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Frijstein]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[van Trommel]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical presentation and diagnosis of Gestational Trophoblastic Disease]]></article-title>
<source><![CDATA[Best Pract Res Clin Obstet Gynaecol. 1 de Julho de]]></source>
<year>2021</year>
<volume>74</volume>
<page-range>42-52</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lurain]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gestational trophoblastic disease I epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol]]></article-title>
<source><![CDATA[Dezembro de]]></source>
<year>2010</year>
<volume>203</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>531-9</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gestational trophoblastic disease epidemiology and trends]]></article-title>
<source><![CDATA[Clinical Obstetrics Gynecology]]></source>
<year>2003</year>
<volume>46</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>541-56</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Serra]]></surname>
<given-names><![CDATA[IGSS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fatores de risco e prognóstico em neoplasia trofoblástica gestacional Uma revisão]]></article-title>
<source><![CDATA[Research, Society and Development. 27 de Setembro de]]></source>
<year>2023</year>
<volume>12</volume>
<numero>9</numero>
<issue>9</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Casanova]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Chuang]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[A]]></surname>
<given-names><![CDATA[R. Goepfert]]></given-names>
</name>
<name>
<surname><![CDATA[N]]></surname>
<given-names><![CDATA[A. Hueppchen]]></given-names>
</name>
<name>
<surname><![CDATA[P]]></surname>
<given-names><![CDATA[M. Weiss]]></given-names>
</name>
<name>
<surname><![CDATA[C]]></surname>
<given-names><![CDATA[R. B. Beckmann]]></given-names>
</name>
</person-group>
<source><![CDATA[Beckmann and Ling's Obstetrics and Gynecology]]></source>
<year>2019</year>
<edition>8th Edition</edition>
<page-range>910-9</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ayres De Campos]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Freire de Oliveira]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Doença gestacional do trofoblasto]]></article-title>
<source><![CDATA[Manual de Ginecologia]]></source>
<year>2011</year>
<page-range>449-60</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Al Riyami]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Al Riyami]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Al Hajri]]></surname>
<given-names><![CDATA[AT]]></given-names>
</name>
<name>
<surname><![CDATA[Al Saidi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Salman]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Al Kalbani]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gestational Trophoblastic Disease at Sultan Qaboos University Hospital Prevalence, Risk Factors, Histological Features, Sonographic Findings, and Outcomes. Oman Med J]]></article-title>
<source><![CDATA[Maio de]]></source>
<year>2019</year>
<volume>34</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>200-4</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Karimi-Zarchi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mortazavizadeh]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Soltani-Gerdefaramrzi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rouhi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Yazdian- Anari]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ahmadiyeh]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Investigation of Risk Factors, Stage and Outcome in Patients with Gestational Trophoblastic Disease since 2001 to 2011 in Iran-Yazd Int J Biomed Sci]]></article-title>
<source><![CDATA[Dezembro de]]></source>
<year>2015</year>
<volume>11</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>166-72</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ngan]]></surname>
<given-names><![CDATA[HYS]]></given-names>
</name>
<name>
<surname><![CDATA[Seckl]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Berkowitz]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Xiang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Golfier]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Sekharan]]></surname>
<given-names><![CDATA[PK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnosis and management of gestational trophoblastic disease 2021 update. Int J Gynaecol Obstet]]></article-title>
<source><![CDATA[Outubro de]]></source>
<year>2021</year>
<volume>155</volume>
<numero>Suppl 1</numero>
<issue>Suppl 1</issue>
<page-range>86-93</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Altman]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
<name>
<surname><![CDATA[Bentley]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Murray]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bentley]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Maternal Age-Related Rates of Gestational Trophoblastic Disease]]></article-title>
<source><![CDATA[Obstet Gynecol]]></source>
<year>2008</year>
<volume>112</volume>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sebire]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
<name>
<surname><![CDATA[Foskett]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Fisher]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Rees]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Seckl]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Newlands]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk of partial and complete hydatidiform molar pregnancy in relation to maternal age]]></article-title>
<source><![CDATA[BJOG. 22 de Janeiro de]]></source>
<year>2002</year>
<volume>109</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>99-102</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sebire]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
<name>
<surname><![CDATA[Fisher]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Foskett]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rees]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Seckl]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Newlands]]></surname>
<given-names><![CDATA[ES]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy]]></article-title>
<source><![CDATA[BJOG. 22 de Janeiro de]]></source>
<year>2003</year>
<volume>110</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>22-6</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Capozzi]]></surname>
<given-names><![CDATA[VA]]></given-names>
</name>
<name>
<surname><![CDATA[Butera]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Armano]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Monfardini]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Gaiano]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gambino]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Obstetrics outcomes after complete and partial molar pregnancy Review of the literature and meta-analysis]]></article-title>
<source><![CDATA[European Journal of Obstetrics and Gynecology and Reproductive Biology. 1 de Abril de]]></source>
<year>2021</year>
<volume>259</volume>
<page-range>18-25</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Buza]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gestational Trophoblastic Disease Contemporary Diagnostic Approach]]></article-title>
<source><![CDATA[Surg Pathol Clin. 1 de Junho de]]></source>
<year>2022</year>
<volume>15</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>197-218</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Buza]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Hui]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Genotyping diagnosis of gestational trophoblastic disease frontiers in precision medicine]]></article-title>
<source><![CDATA[Modern Pathology. 1 de Setembro de]]></source>
<year>2021</year>
<volume>34</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1658-72</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramírez]]></surname>
<given-names><![CDATA[LAC]]></given-names>
</name>
<name>
<surname><![CDATA[Maestá]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Bianconi]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
<name>
<surname><![CDATA[Jankilevich]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Otero]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mejía]]></surname>
<given-names><![CDATA[CRV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical Presentation, Treatment Outcomes, and Resistance-related Factors in South American Women with Low-risk Postmolar Gestational Trophoblastic Neoplasia Revista Brasileira de Ginecologia e Obstetrícia]]></article-title>
<source><![CDATA[Agosto de]]></source>
<year>2022</year>
<volume>44</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>746-54</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Saxena]]></surname>
<given-names><![CDATA[YK]]></given-names>
</name>
<name>
<surname><![CDATA[Rathi]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
<name>
<surname><![CDATA[Chitra]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Host and risk factors for gestational trophoblastic disease a hospital-based analysis from India. Med Sci Monit]]></article-title>
<source><![CDATA[Outubro de]]></source>
<year>2003</year>
<volume>9</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>CR442-7</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[HLFF]]></given-names>
</name>
<name>
<surname><![CDATA[Doyle]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Influence of oral contraceptives in the development of post-molar trophoblastic neoplasia-A systematic review]]></article-title>
<source><![CDATA[Gynecol Oncol]]></source>
<year>2006</year>
<volume>100</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>579-85</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Braga]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Maestá Phd]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Short Bsc]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Savage]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Harvey Phd]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Seckl]]></surname>
<given-names><![CDATA[MJ.]]></given-names>
</name>
</person-group>
<source><![CDATA[Modern hormone contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole]]></source>
<year>2024</year>
</nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alazzam]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Coleman]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Hancock]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Drew]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Wilson]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predicting gestational trophoblastic neoplasia (GTN) is urine hCG the answer? Gynecol Oncol]]></article-title>
<source><![CDATA[Setembro de]]></source>
<year>2011</year>
<volume>122</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>595-9</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="">
<collab>Sociedade Portuguesa de Ginecologia</collab>
<source><![CDATA[Cancro Ginecológico - Consensos Nacionais 2020]]></source>
<year>2023</year>
<page-range>163-80</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marques]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Cunha]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Doença Trofoblástica Gestacional]]></article-title>
<source><![CDATA[Acta Radiológica Portuguesa]]></source>
<year>2012</year>
<page-range>35-40</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Silva da]]></surname>
<given-names><![CDATA[ALM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gestational trophoblastic neoplasia Novelties and challenges]]></article-title>
<collab>Monteiro K do N.Sun SY.Borbely AU</collab>
<source><![CDATA[Placenta. 1 de Dezembro de]]></source>
<year>2021</year>
<volume>116</volume>
<page-range>38-42</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weng]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Benjoed]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Tang]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation and simplification of risk factors in FIGO 2000 scoring system for gestational trophoblastic neoplasia a 19- year retrospective analysis]]></article-title>
<source><![CDATA[J Zhejiang Univ Sci B. 15 de Março de]]></source>
<year>2022</year>
<volume>23</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>218-29</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kong]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Wan]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Feng]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ren]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management and Predictors of Treatment Failure in Patients with Chemo-Resistant/Relapsed Gestational Trophoblastic Neoplasia with Lung Metastasis]]></article-title>
<source><![CDATA[J Clin Med]]></source>
<year>2022</year>
<volume>11</volume>
<numero>24</numero>
<issue>24</issue>
</nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Borella]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Cosma]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ferraioli]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Preti]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gallio]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Valabrega]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[From Uterus to Brain: An Update on Epidemiology, Clinical Features, and Treatment of Brain Metastases From Gestational Trophoblastic Neoplasia]]></article-title>
<source><![CDATA[Front Oncol]]></source>
<year>2022</year>
<page-range>12</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lybol]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Centen]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[CMG]]></given-names>
</name>
<name>
<surname><![CDATA[Ten Kate-Booij]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Verheijen]]></surname>
<given-names><![CDATA[RHM]]></given-names>
</name>
<name>
<surname><![CDATA[Sweep]]></surname>
<given-names><![CDATA[FCGJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands A retrospective cohort study. BJOG]]></article-title>
<source><![CDATA[Novembro de]]></source>
<year>2012</year>
<volume>119</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1465-72</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Albright]]></surname>
<given-names><![CDATA[BB]]></given-names>
</name>
<name>
<surname><![CDATA[Myers]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
<name>
<surname><![CDATA[Moss]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
<name>
<surname><![CDATA[Ko]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Sonalkar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Havrilesky]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Surveillance for gestational trophoblastic neoplasia following molar pregnancy: a cost-effectiveness analysis]]></article-title>
<source><![CDATA[Am J Obstet Gynecol]]></source>
<year>2021</year>
<volume>225</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>513.e1-513.e19</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kong]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Zong]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Cheng]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Wan]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Feng]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management and risk factors of recurrent gestational trophoblastic neoplasia An update from 2004 to 2017. Cancer Med]]></article-title>
<source><![CDATA[Abril de]]></source>
<year>2020</year>
<volume>9</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>2590-9</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hancock]]></surname>
<given-names><![CDATA[BW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Staging and classification of gestational trophoblastic disease]]></article-title>
<source><![CDATA[Bailliere's Best Practice and Research in Clinical Obstetrics and Gynaecology]]></source>
<year>2003</year>
<volume>17</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>869-83</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Biscaro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Braga]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Berkowitz]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnosis, classification and treatment of gestational trophoblastic neoplasia Revista Brasileira de Ginecologia e Obstetrícia]]></article-title>
<source><![CDATA[Janeiro de]]></source>
<year>2015</year>
<volume>37</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>42-51</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clark]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Slater]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Seckl]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment of gestational trophoblastic disease in the 2020s]]></article-title>
<source><![CDATA[Curr Opin Obstet Gynecol. 1 de Fevereiro de]]></source>
<year>2021</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>7-12</page-range></nlm-citation>
</ref>
<ref id="B40">
<label>40</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soper]]></surname>
<given-names><![CDATA[JT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gestational Trophoblastic Disease Current Evaluation and Management]]></article-title>
<source><![CDATA[Obstetrics and gynecology. 1 de Fevereiro de]]></source>
<year>2021</year>
<volume>137</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>355-70</page-range></nlm-citation>
</ref>
<ref id="B41">
<label>41</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schmid]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Nagai]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Agarwal]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Hancock]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Savage]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Sebire]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prognostic markers and long-term outcome of placental-site trophoblastic tumours a retrospective observational study]]></article-title>
<source><![CDATA[The Lancet . 4 de Julho de]]></source>
<year>2009</year>
<volume>374</volume>
<numero>9683</numero>
<issue>9683</issue>
<page-range>48-55</page-range></nlm-citation>
</ref>
<ref id="B42">
<label>42</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[França]]></surname>
<given-names><![CDATA[ACG]]></given-names>
</name>
<name>
<surname><![CDATA[Uberti]]></surname>
<given-names><![CDATA[EMH]]></given-names>
</name>
<name>
<surname><![CDATA[Muller]]></surname>
<given-names><![CDATA[KP]]></given-names>
</name>
<name>
<surname><![CDATA[Cardoso]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
<name>
<surname><![CDATA[Giguer]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[El Beitune]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Emotional and Clinical Aspects Observed in Women with Gestational Trophoblastic Disease A Multidisciplinary Action]]></article-title>
<source><![CDATA[Revista Brasileira de Ginecologia e Obstetricia. 1 de Abril de]]></source>
<year>2022</year>
<volume>44</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>343-51</page-range></nlm-citation>
</ref>
<ref id="B43">
<label>43</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodriguez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Goldstein]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
<name>
<surname><![CDATA[Berkowitz]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treating gestational trophoblastic disease Expert Opin Pharmacother]]></article-title>
<source><![CDATA[Dezembro de]]></source>
<year>2010</year>
<volume>11</volume>
<numero>18</numero>
<issue>18</issue>
<page-range>3027-39</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
